In this installment of the Leadership Perspectives series, we speak with some of the top Medical Affairs leaders from Johnson & Johnson as they think about the rapid new ascension of Medical Affairs into a fully integrated strategic business partner.
In this webinar, an MSL, a Medical Field Excellence Leader, and a Solution Provider discuss an aligned partnership to supercharge scientific exchange.
There is growing interest globally in using real-world data (RWD) and real-world evidence (RWE) for applications including regulatory decisions, health technology assessment (HTA), pharmacovigilance and more. However, Asia currently lacks a framework to effectively collect and utilize a broad range of RWD/RWE.
This podcast explores how Medical Affairs can implement a Netflix-like, education streaming strategy to obtain direct access to HCPs and engage with them repeatedly.
Here John Pracyk, MD, PhD, MBA, MAPS President of the Americas Region speaks with some of the top Medical Affairs leaders from Johnson & Johnson as they share their perspective on the impact of Digital on Healthcare.
MAPS speaks with Ariel Katz, co-founder and CEO of H1, about the future of the Medical Affairs function and the factors driving the current pace of change.
This webinar explores real world and novel approaches to customizing and creating Medical Affairs metrics that are relevant, and most meaningful.
Pharmaceutical teams need a different way to approach working virtually. The secret isn’t adding more virtual calls, but unlocking the strategic power of virtual work. Download this white paper to see how your peers are achieving more, with fewer meetings.
Download the MAPS Media & Sponsorship Prospectus 2021
MAPS speaks with Ariel Katz, co-founder and CEO of H1, about the factors driving the evolution of Medical Affairs and look at the shape of the function in 2030 and beyond.